期刊文献+

国外儿童青少年精神分裂症治疗研究进展 被引量:10

Foreign Treatment Development about Children and Youth Schizophrenia
下载PDF
导出
摘要 本文综述了药物治疗儿童青少年精神分裂症的研究进展,并对药物副作用、安全性和耐受性作了详尽介绍。
出处 《中国健康心理学杂志》 2011年第5期626-628,共3页 China Journal of Health Psychology
  • 相关文献

参考文献15

  • 1Vishal M, Yael D, Daniel R. Child and adolescent schizophrenia: Pharmacological approaehes[J]. Expert opin. Pharmacother, 2008,9 (12) : 2053-2068.
  • 2Shaw P,Sporn A,Gogtay N ,et al. Childhood--onset schizophrenia: a double-- blind, randomized clozapine -- olanzapine Comparison[J ]. Arch Gen Psychiatry, 2006,63 (7): 721-730.
  • 3Mozes T, Ebert T, Michal S E,et al. An open--label randomized comparison of olanzapine verscus riperidone in the treatment of child- hood--outset schizophrenia[J]. J child Adolesc Psychopharmacol, 2006,16:393-403.
  • 4Kumra S, Oberstar J V, Sikich L,et al. Efficacy and toterahility sec ond- generation antipsyehotics in children and adolescents with schizophrenia[J]. Schizophr Bull,2008,34(1):60-70.
  • 5Schimmelmann B G. A propective 12--week study of quetiapine in adolescents with schizophrenia spectrum disorders[J]. J child Ado- lesc Psychopharmacol, 2 0 0 7,17: 7 6 8- 7 7 8.
  • 6Shaw J A, Lewis J E,Pascal S,et al. A study of quetiapine:Efficacy and tolerability in psychotic adolescents [J]. J child Adolesc Psy chopharmacol, 2001,11 : 415-424.
  • 7Patel N,sierk P, Dorson P, et al. Experience with ziprasidone[J]. J Am Acad child Adolesc Psychiatry, 2002,41 (5) : 495.
  • 8Correll cu, Carlson H E. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents[J]. J Am Acad Child Adolese Psychitry, 2006,45 (7) : 771-791.
  • 9Wu R R,Zhao J P. Lifestyle intervention and metformin for trea- ment of antipsyehotic--induced weight gain:a randomized controlled trial[J]. JAMA,2008,299 : 185-193.
  • 10Blair J, Scahill L, State M, et al: Electrocardiographic changes in children and adolesents treament with ziphasidone: a Prospective study[J]. J Am Acad Child Adolesc Psychiatry, 2005,44 (1):73- 79.

同被引文献93

  • 1陈云芳,张立勇.利培酮治疗少年儿童首发精神分裂症的疗效及安全性观察[J].中国神经精神疾病杂志,2005,31(5):395-396. 被引量:10
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD-Ⅲ)[M].济南:山东科学技术出版社,2001.87-88.
  • 3中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD.3)[M].3版,济南:山东科学技术出版社,2001:87-89.
  • 4王永炎.临床中医内科学[M].北京:北京出版社,1994.1987-1990.
  • 5汪向东.心理卫生评定量表手册[M]增订版[M].北京:中国心理卫生杂志出版社,1999.120-129.
  • 6中华医学会精神科分会.中国精神障碍分类与诊断标准[M].第3版.济南:山东科学技术出版社,2001:75-77.
  • 7汪向东,王希林,马弘.心理卫生评定量表手册增订版[M].北京:中国心理卫生杂志社,1999:235~237.
  • 8舒良.精神分裂症防治指南[M].北京:北京大学医学出版社,2007:64.
  • 9KANE JM, CANAS F, KRAMER M, et ol. Treatment of schizophrenia with paliperidone extended release extended tablets a 6-week placebo controlled trial[J]. Schisophr Res, 2007, 90(1-3): 147-161.
  • 10DAVIDSON M, EMSLEY R, KRAMER M, et al. Efficacy, safety and early response of paliperidone extended- release tablets (paliperidone ER): results of a 6-weeek, randomized, placebo-controlled study[J]. Schisophr Res, 2007, 93(1-3) : 117-130.

引证文献10

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部